Cidqo

Barcelona, Spain Founded: 2012 • Age: 14 yrs Acquired By Suanfarma
Pharmaceuticals and intermediates are developed using combinatorial chemistry.
Request Access

About Cidqo

Cidqo is a company based in Barcelona (Spain) founded in 2012 was acquired by Suanfarma in March 2013.. Cidqo offers products and services including Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance. Cidqo operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Barcelona, Spain
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Cidqo 2012, Sl
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $55.01 K (USD), Grant

    Oct 31, 2015

  • Investors
    Suanfarma

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Suanfarma

    (Mar 07, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cidqo

Cidqo offers a comprehensive portfolio of products and services, including Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Designs synthetic routes for APIs and intermediates.

Develops and validates methods for HPLC and spectroscopy.

Evaluates patents and innovative chemical routes.

Provides regulatory support and process optimization.

Funding Insights of Cidqo

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $55,006
  • First Round

    (01 May 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2015 Amount Grant - Cidqo Valuation

investors

May, 2015 Amount Grant - Cidqo Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cidqo

Cidqo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Suanfarma, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Generics, nutraceuticals, and APIs are developed by Suanfarma.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cidqo

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cidqo

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cidqo Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cidqo

Cidqo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cidqo

Frequently Asked Questions about Cidqo

When was Cidqo founded?

Cidqo was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is Cidqo located?

Cidqo is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

What does Cidqo do?

Cidqo was established in 2012 in Barcelona, Spain, within the pharmaceuticals sector. Combinatorial chemistry is employed for developing active pharmaceutical ingredients and intermediates. Services in API production are provided, with completed developments including N-Acetyl Cysteine (NAC), L-Carnosine, Dapoxetine, Tenofovir, Rivastigmine, and Diacerein. Ongoing efforts focus on Cinacalcet HCL, Adenine, and Emtricitabine.

Who are the top competitors of Cidqo?

Cidqo's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does Cidqo offer?

Cidqo offers Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance.

Who are Cidqo's investors?

Cidqo has 3 investors. Key investors include Suanfarma, European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available